Emergent BioSolutions financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

이머전트 바이오솔루션스NYSE:EBS · New York Stock Exchange · Healthcare

$7.24+14.38%

2026-10-05 close

Emergent BioSolutions's published financial data is dated 2026-10-04. 2024 revenue was $1.04B. 2024 operating profit was −$84M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy